Su tumore de su colon, connotu fintzas comente a tumore colorectale, est una maladia grave e potentzialmente mortale.
Est su de tres tumores prus comunes in sos Istados Unidos e sa segunda causa printzipale de morte pro tumores.
Sa pertzentuale generale de subravivèntzia a 5 annos pro su tumore a su colon est de belle su 65%, ma custu vàriat a segunda de s'istàdiu in su cale su tumore est istadu diagnosticadu.
Si est istadu agatadu a su cumintzu, su tassu de subravivèntzia a 5 annos podet èssere artu a su 90%, ma si su tumore s'est ispartu a àteras partes de su corpus, su tassu de subravivèntzia calat a belle 111%.
Est de importu a notare chi sos tassos de subravivèntzia sunt petzi istimas e sos resurtados individuales podent variare.
Sa ischermada regulare e su tratamentu lestru podent minimare in manera significativa su riscu chi su tumore de su colon divenat mortale.
Andersen LD, Remington P, Trentham-Dietz A, Reeves M: Assessing a decade of progress in cancer control. Oncologist. 2002, 7 (3): 200-4.
Wang YG, Chen KX, Wu GL, Song FJ: An analysis: colon cancer mortality in Tianjin, China, from 1981 to 2000. World J Gastroenterol. 2005, 11 (6): 895-8.
Tsuji K, Harashima E, Nakagawa Y, Urata G, Shirataka M: Time-lag effect of dietary fiber and fat intake ratio on Japanese colon cancer mortality. Biomed Environ Sci. 1996, 9 (2-3): 223-8.
Kanter MH, Schottinger JE, Joshua A, Slezak JM: Beyond Screening: An Interim Report and Analysis of a Multimodal Initiative to Decrease Colon Cancer Mortality. Jt Comm J Qual Patient Saf. 2022, 48 (8): 388-394.
Tseng CH: Diabetes but not insulin is associated with higher colon cancer mortality. World J Gastroenterol. 2012, 18 (31): 4182-90.
Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, McCullough ML, Calle EE, Thun MJ: Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States). Cancer Causes Control. 2001, 12 (10): 927-34.
['Disclaimer: mèdicu']
['Custu giassu est fatu po istudiare e informae sa zente e non est unu giassu de consultatzione o de azudu.']
['Sa informassione frunida no est de impreare pro diagnosticare o curare unu problema de salude o una maladia, e sos chi chircant consìgios mèdicos personales si depent cuntatare cun unu mèdicu autorizadu.']
["S'arricordaus ca sa retza neurali chi creat rispostas a is pregontas est imperfeta candu si chistionat de nùmerus, po nai su nùmeru de personas chi tenint una maladia."]
["Chirca semper su parre de su dotore tuo o de un'àteru dotore cualificadu pro cale si siat cunditzione mèiga. No disconnoscas mai su parre de unu professionista mèigu o non bi tardes a l'agatare pro carchi cosa chi as lèghidu in custu situ. Si tenes pensamentos de tènnere un'emergèntzia mèiga, telefona a su 911 o bae a su pronto soccorsu prus acanta."]
['Disclaimer: deretu de autore']
['Sa Digital Millennium Copyright Act de su 1998, 17 U.S.C. § 512 (sa DMCA) donat unu recursu a is propietàrius de deretus de autori chi pensant chi unu materiali chi aparit in Internet ofendet is deretus insoru assuta de sa lei de su deretu de autori de is IUA. ']
["Si creis de bona fidi chi calicunu cuntènniu o materiale postu a disponimentu in su giassu o in is servìtzios nostros at ofesu is deretus de autore tuos, tui (o s'agenti tuo) nos podes imbiare una comunicatzioni domandendi de nde bogare su cuntènniu o su materiale, o de nde blocare s'atzessu."]
['Sos annùntzios depent èssere imbiados pro iscrittu pro mèdiu de posta eletrònica (càstia sa setzione "Cuntatu" pro s\'indiritzu de posta eletrònica). ']
["Sa DMCA recheret chi sa notìfica tua de sa presunta violatzione de copyright incluat sas informatziones sighentes: (1) descritzione de s'òpera amparada dae copyright chi est ogetu de sa presunta violatzione; (2) descritzione de su chi si narat chi est unu cuntènnidu chi diat pòdere èssere istadu violadu e informatziones bastantes pro nos permìtere de localizare su cuntènnidu; (3) informatziones pro ti cuntatare, intre cales s'indiritzu tuo, su nùmeru de telèfono e s'indiritzu de posta eletrònica; (4) una decraratzione tua pro nàrrere chi tenes bona fide chi su cuntènnidu de sa manera chi ses lamentende non est autorizadu dae su mere de su copyright, dae s'agente suo o dae cale si siat lege."]
["5) una decraratzione firma tua, suta pena de perjuria, chi is informatziones in sa notìfica sunt acuradas e chi tenes s'autorizatzione pro aplicare is deretos de autore chi sunt istados violados; "]
['e (6) una firma fìsica o eletrònica de su mere de su deretu de autore o de una persone autorizada a agire a nùmene suo. ']
['Si non ponis totu is informatzionis de prima podit essi chi su protzedimentu ti siat tardau.']
['Contatu']
['Manda·nos una mail cun cale si siat dimanda o sugerimentu.']
How deadly is colon cancer?
Colon cancer, also known as colorectal cancer, is a serious and potentially deadly disease.
It is the third most common cancer in the United States and the second leading cause of cancer deaths.
The overall 5-year survival rate for colon cancer is approximately 65%, but this varies depending on the stage at which the cancer is diagnosed.
If caught early, the 5-year survival rate can be as high as 90%, but if the cancer has spread to other parts of the body, the survival rate drops to around 111%. Early detection and treatment are crucial for improving the chances of survival.
It is important to note that survival rates are only estimates and individual outcomes may vary.
Regular screening and prompt treatment can significantly reduce the risk of colon cancer becoming deadly.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Prus o mancu']
['BioMedLib impreat elaboradores automatizados (algoritmos de imparu automàticu) pro generare parigas de dimandas e rispostas.']
['Incumentzamus cun 35 milliones de publicatziones biomèdicas de PubMed/Medline. E puru, pàginas web de RefinedWeb.']
